# Navigating the Clinical Trial Supply Chain: Vetting Cold Chain Logistics and Vendor Compliance
Maintaining the integrity of the **clinical trial supply chain** has become one of the most critical challenges in modern drug development. With the rise of highly sensitive biological materials, cell and gene therapies, and mRNA-based investigational medicinal products (IMPs), the margin for environmental error has virtually vanished. A single temperature excursion during transport or storage can render an entire batch of investigational drugs inactive, jeopardizing patient safety, invalidating months of clinical data, and costing pharmaceutical sponsors millions of dollars.
To safeguard clinical assets, trial administrators, compliance officers, and logistics directors must establish robust, GxP-compliant standard operating procedures (SOPs) and rigorously vet third-party logistics (3PL) partners and clinical couriers.